China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

Company Overview

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Key Stats

• Today's Range: $0.37 to $0.39
• 50-Day Range: $0.39 to $0.80
• 52-Week Range: $0.37 to $6.39
• Volume: 71,735 shs
• Average Volume: 729,375 shs
• Market Capitalization: $1.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SXTC Stock Analysis - Frequently Asked Questions

How have SXTC shares performed this year?

China SXT Pharmaceuticals' stock was trading at $3.97 at the beginning of the year. Since then, SXTC shares have decreased by 90.3% and is now trading at $0.3833.
View the best growth stocks for 2024 here.

When did China SXT Pharmaceuticals' stock split?

China SXT Pharmaceuticals's stock reverse split before market open on Thursday, October 5th 2023. The 1-25 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that China SXT Pharmaceuticals investors own include MARA (MARA), NIO (NIO), Meta Platforms (META), Alibaba Group (BABA), HEXO (HEXO), JD.com (JD) and Blink Charging (BLNK).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SXTC
• CUSIP: N/A
• CIK: 1723980
• Web: www.sxtchina.com
• Phone: 8652386299087
• Fax: N/A
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 1.60
• Quick Ratio: 1.51

Sales & Book Value

• Annual Sales: $1.93 million
• Price / Sales: 0.78
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $30.46 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 4,060,000
• Free Float: 3,902,000
• Market Cap: $1.51 million
• Optionable: Not Optionable
• Beta: 1.16